Skip to content

Neuroimaging Biomarker for Seizures

Neuroimaging Biomarker for Seizures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03441867
Acronym
NIBMSZS
Enrollment
224
Registered
2018-02-22
Start date
2017-09-15
Completion date
2022-09-14
Last updated
2022-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conversion Disorder, Epilepsy, Head Injury, Magnetic Resonance Imaging, Non-Epileptic Seizure, Seizure Disorder, Seizure Disorder, Post Traumatic, Traumatic Brain Injury

Keywords

Cognitive Behavioral Therapy, Veterans, Quality of Life, Stress Disorders, Post-Traumatic, Convulsion, Non-Epileptic, civilians, healthy volunteers

Brief summary

This multi-site study will examine patients with epilepsy (ES) following head injury \[i.e., posttraumatic epilepsy (PTE)\] and posttraumatic psychogenic Non-epileptic seizures (PNES) and will compare them to patients with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.

Detailed description

Numerous Veterans and civilians have seizures, which can be epileptic or nonepileptic in nature. Epileptic seizures are caused by abnormal brain cell firing. Nonepileptic seizures appear similar to epileptic seizures, but are associated with traumatic experiences and underlying psychological stressors. Both types of seizure are common and disabling, and many patients with seizures do not have adequate control resulting in loss of quality of life. In this proposed 3-site study ( Providence, RI and Birmingham, AL), which are epilepsy centers with expertise both in epilepsy and psychogenic nonepileptic seizures (PNES), we will enroll 88 patients with video-EEG confirmed PNES and 88 with confirmed post-traumatic epilepsy (PTE) and will obtain functional neuroimaging before and after they receive a behavioral treatment - Cognitive Behavioral Therapy for Seizures. The functional neuroimaging studies in these patients will be compared to patients with traumatic brain injury without seizures to test the hypothesis that the faulty processing of emotions and stress in patients with PNES/PTE and abnormal brain connectivity have unique signals in patients with seizures compared to Veterans without seizures and that the neuroimaging signatures can be modified using behavioral intervention. Impact: This grant application for the first study investigating mechanisms of PNES and PTE will provide increased understanding of neural circuitry in PTE and PNES, which can inform PTE and PNES treatments and could change clinical neurologic and psychiatric practice for PTE and PNES. Participants will be recruited at the Providence VA Medical Center, Rhode Island Hospital, and University of Alabama, Birmingham (UAB).

Interventions

BEHAVIORALCognitive Behavioral Therapy for Seizures

CBT-informed psychotherapy for patients with PNES and PTE

OTHERStandard Medical Care

Observational - standard medical care

Sponsors

University of Alabama at Birmingham
CollaboratorOTHER
Rhode Island Hospital
CollaboratorOTHER
Birmingham, Alabama VA Medical Center
CollaboratorFED
United States Department of Defense
CollaboratorFED
Ocean State Research Institute, Inc.
CollaboratorOTHER
Brown University
CollaboratorOTHER
Providence VA Medical Center
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

The neuroimaging analysis will be masked.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Inclusion criteria for PNES, ES and TBI (w/o PNES or ES) participants * Individuals with history of documented TBI (any severity). * Males and Females ages 18-60 years . * Women of child bearing potential, if currently using appropriate contraception. Inclusion criteria of PNES and ES participants. * Diagnosed by video/EEG with lone PNES or by EEG with lone ES. * Patients must have at least 1 PNES or 1 ES during the year prior to enrollment.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Number of Epileptic SeizuresBaseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baselineepileptic seizure frequency (ES), collected prospectively, using a daily seizure calendar
Number of Nonepileptic Seizures (NES)Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baselinepsychogenic nonepileptic seizure (NES) frequency, collected prospectively, using a daily seizure calendar
Structural and Functional NeuroimagingBaseline and week 13Brain MRI scans

Secondary

MeasureTime frameDescription
Beck Depression Inventory-II (BDI-II)Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baselineThe BDI-II assesses depression severity from 0 (no Depression-related symptom) to 3 (severe) on each question. The highest possible score is 51, relating to the worst outcome.
Beck Anxiety Inventory (BAI)Baseline, Weeks 6 and 10, 8 months post baseline, 12 months post baselineThe BDI-II assesses anxiety severity from 0 (no Anxiety-related symptom) to 3 (severe) on each question.
Quality of Life in Epilepsy-31 (QOLIE-31)Baseline, Weeks 6 and 10his is a 31-item self-report scale used in the seizure population to evaluate Quality of Life. The lowest possible score is 0 and the highest possible score is 100, reflecting a better quality of life.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026